Eprocliv

Eprocliv combines Metformin Hydrochloride and Sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Eprocliv is primarily used for managing type 2 diabetes in adults. It works by improving insulin sensitivity and increasing insulin production, helping to regulate blood sugar levels. This medication is often prescribed alongside diet and exercise to achieve optimal results.

Common effects of Eprocliv may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and temporary as the body adjusts to the medication.

Eprocliv should be used with caution in individuals with kidney or liver problems. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Regular monitoring of blood sugar levels is recommended.

Eprocliv may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol consumption should be limited, as it can enhance the risk of low blood sugar. Always inform your healthcare provider about all medications you are taking.